COLLEGIUM PHARMACEUTICAL INC's ticker is and the CUSIP is 19459JAA2. A total of 8 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018,318 | +0.8% | 1,985,000 | 0.0% | 0.09% | +11.4% |
| Q2 2023 | $2,001,330 | -5.9% | 1,985,000 | 0.0% | 0.08% | -4.8% |
| Q1 2023 | $2,125,886 | -83.7% | 1,985,000 | -84.5% | 0.08% | -83.6% |
| Q4 2022 | $13,047,324 | +18.6% | 12,809,000 | 0.0% | 0.51% | +20.1% |
| Q3 2022 | $10,999,000 | -2.2% | 12,809,000 | 0.0% | 0.42% | -6.0% |
| Q2 2022 | $11,244,000 | -37.4% | 12,809,000 | -29.1% | 0.45% | -19.7% |
| Q1 2022 | $17,964,000 | +64.6% | 18,059,000 | +63.5% | 0.56% | +64.9% |
| Q4 2021 | $10,913,000 | -2.5% | 11,044,000 | 0.0% | 0.34% | +1.5% |
| Q3 2021 | $11,195,000 | +13.2% | 11,044,000 | +22.1% | 0.33% | +12.8% |
| Q2 2021 | $9,886,000 | +1.4% | 9,044,000 | +1.6% | 0.30% | -11.6% |
| Q1 2021 | $9,745,000 | +191.8% | 8,900,000 | +161.8% | 0.34% | +280.7% |
| Q4 2020 | $3,340,000 | – | 3,400,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 17,500,000 | $189,560,000 | 2.40% |
| STEELHEAD PARTNERS LLC | 21,000,000 | $22,877,000 | 1.73% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,245,000 | $33,292,000 | 1.33% |
| DeepCurrents Investment Group LLC | 8,900,000 | $9,745,000 | 0.34% |
| LINDEN ADVISORS LP | 28,000,000 | $30,455,000 | 0.23% |
| Teton Advisors, Inc. | 500,000 | $542,000 | 0.08% |
| Verition Fund Management LLC | 2,589,000 | $2,823,000 | 0.03% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 190,000 | $206,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 18,000,000 | $19,628,000 | 0.02% |
| GABELLI FUNDS LLC | 3,000,000 | $3,254,000 | 0.02% |